Anbio Biotechnology (NNNN)

Currency in USD
42.80
-1.77(-3.97%)
Closed·
After Hours
42.61-0.19(-0.44%)
·
NNNN Scorecard
Full Analysis
Stock has taken a big hit over the last week
NNNN is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
41.8044.37
52 wk Range
5.1855.65
Key Statistics
Prev. Close
44.57
Open
44.37
Day's Range
41.8-44.37
52 wk Range
5.18-55.65
Volume
85.48K
Average Volume (3m)
121.14K
1-Year Change
-
Book Value / Share
-
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
NNNN Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple

Anbio Biotechnology News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Anbio Biotechnology Company Profile

Anbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationally. It offers SARS-CoV-2 antigen rapid and SARS-CoV-2/influenza A/B antigen rapid tests; and lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification, chemiluminescence immunoassay, and reverse-transcription polymerase chain reaction products. It serves over-the-counter, point-of-care testing, and laboratory markets. The company was incorporated in 2021 and is based in Frankfurt am Main, Germany.

Compare NNNN to Peers and Sector

Metrics to compare
NNNN
Peers
Sector
Relationship
P/E Ratio
791.7x−0.2x−0.5x
PEG Ratio
−16.98−0.190.00
Price/Book
109.3x3.2x2.6x
Price / LTM Sales
229.5x10.0x3.3x
Upside (Analyst Target)
-169.6%45.4%
Fair Value Upside
Unlock7.0%7.7%Unlock

Earnings

Latest Release
Apr 28, 2025
EPS / Forecast
-0.03 / --
Revenue / Forecast
2.34M / --
EPS Revisions
Last 90 days

NNNN Income Statement

People Also Watch

260.07
AVAV
-2.83%
7.570
TRON
-10.73%
168.10
CRCL
-8.40%
31.68
BMNR
-8.55%
208.33
LEU
-3.28%

FAQ

What Stock Exchange Does Anbio Biotechnology Trade On?

Anbio Biotechnology is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Anbio Biotechnology?

The stock symbol for Anbio Biotechnology is "NNNN."

What Is the Anbio Biotechnology Market Cap?

As of today, Anbio Biotechnology market cap is 1.88B.

What Is Anbio Biotechnology's Earnings Per Share (TTM)?

The Anbio Biotechnology EPS (TTM) is 0.06.

From a Technical Analysis Perspective, Is NNNN a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.

How Many Times Has Anbio Biotechnology Stock Split?

Anbio Biotechnology has split 0 times.

How Many Employees Does Anbio Biotechnology Have?

Anbio Biotechnology has 27 employees.

What is the current trading status of Anbio Biotechnology (NNNN)?

As of 03 Aug 2025, Anbio Biotechnology (NNNN) is trading at a price of 42.80, with a previous close of 44.57. The stock has fluctuated within a day range of 41.80 to 44.37, while its 52-week range spans from 5.18 to 55.65.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.